Vincent Jarlier

21.2k total citations · 2 hit papers
266 papers, 14.4k citations indexed

About

Vincent Jarlier is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Vincent Jarlier has authored 266 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Infectious Diseases, 151 papers in Epidemiology and 108 papers in Molecular Medicine. Recurrent topics in Vincent Jarlier's work include Tuberculosis Research and Epidemiology (114 papers), Antibiotic Resistance in Bacteria (108 papers) and Mycobacterium research and diagnosis (101 papers). Vincent Jarlier is often cited by papers focused on Tuberculosis Research and Epidemiology (114 papers), Antibiotic Resistance in Bacteria (108 papers) and Mycobacterium research and diagnosis (101 papers). Vincent Jarlier collaborates with scholars based in France, United States and Belgium. Vincent Jarlier's co-authors include Emmanuelle Cambau, Wladimir Sougakoff, Hiroshi Nikaido, A. Philippon, M. H. Nicolas, G. Fournier, C. Truffot-Pernot, Nicolas Véziris, J. Robert and Alexandra Aubry and has published in prestigious journals such as Science, The Lancet and Nature Communications.

In The Last Decade

Vincent Jarlier

258 papers receiving 13.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

2004 1.6k citations Koen Andries, Peter Verhasselt et al. Science profile →
Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility Patterns

1988 1.3k citations Vincent Jarlier et al. profile →

Peers

Countries citing papers authored by Vincent Jarlier

Since Specialization

Citations

This map shows the geographic impact of Vincent Jarlier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Jarlier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Jarlier more than expected).

Fields of papers citing papers by Vincent Jarlier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Jarlier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Jarlier. The network helps show where Vincent Jarlier may publish in the future.

Co-authorship network of co-authors of Vincent Jarlier

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Jarlier. A scholar is included among the top collaborators of Vincent Jarlier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Jarlier. Vincent Jarlier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	China Against Drug Resistance (CARE) Point Prevalence Study: A Tool for Evaluating Hospital Acquired Infections and Antimicrobial Prescription at Patient Bedside 2024 ·Yonghong Xiao, (unknown), Jing Yang, (unknown), (unknown), (unknown), (unknown), Yukun Chen, Wenxiang Huang, (unknown), (unknown), (unknown), (unknown), Vincent Jarlier	0
2	Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy 2023 ·PLoS neglected tropical diseases ·Aurélie Chauffour, Nacer Lounis, Koen Andries, Vincent Jarlier, Nicolas Véziris, Alexandra Aubry	5
3	La transmission croisée dans la résistance aux antibiotiques : son contrôle dans les hôpitaux français 2019 ·Bulletin de l Académie Nationale de Médecine ·Vincent Jarlier	1
4	Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis? 2017 ·Journal of Antimicrobial Chemotherapy ·Thomas Maitre, (unknown), Aurélie Chauffour, Christine Bernard, Najoua El Helali, Vincent Jarlier, Florence Reibel, P. Chavanet, Alexandra Aubry, Nicolas Véziris	25
5	First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs 2015 ·BMC Infectious Diseases ·Xiaojun Ma, Yinghong Wu, (unknown), Qian Xu, Bijie Hu, Yuxing Ni, Anhua Wu, (unknown), Vincent Jarlier, J. Robert	27
6	Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients 2014 ·Journal of Cystic Fibrosis ·Anne‐Laure Roux, Émilie Catherinot, Nathalie Soismier, Béate Heym, Gil Bellis, Lydie Lemonnier, R. Chiron, Brigitte Fauroux, Muriel Le Bourgeois, À. Munck, Isabelle Pin, Isabelle Sermet‐Gaudelus, Cristina Gutierrez, Nicolas Véziris, Vincent Jarlier, Emmanuelle Cambau, Jean‐Louis Herrmann, Didier Guillemot, Jean‐Louis Gaillard	69
7	Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis 2012 ·Bioorganic & Medicinal Chemistry ·Catherine Gomez, (unknown), Nawal Serradji, Aazdine Lamouri, Alix Pantel, (unknown), Vincent Jarlier, Guillaume Anquetin, Alexandra Aubry	14
8	The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System 2012 ·Clinical Microbiology and Infection ·Marlieke E.A. de Kraker, Vincent Jarlier, J. Monen, Ole Eske Heuer, (unknown), Hajo Grundmann	299
9	Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm (41) and rrl Sequencing 2010 ·Antimicrobial Agents and Chemotherapy ·Sylvaine Bastian, Nicolas Véziris, Anne‐Laure Roux, Florence Brossier, Jean‐Louis Gaillard, Vincent Jarlier, Emmanuelle Cambau	269
10	Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis 2009 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), C. Truffot-Pernot, Koen Andries, Vincent Jarlier, Nicolas Véziris	61
11	Molecular characterization of Isoniazid and Rifampicin resistance strains of Mycobacterium tuberculosis isolated from new tuberculosis cases in Lagunes Region (Cote DIvoire) 2008 ·Scientific Research and Essays ·(unknown), (unknown), Florence Brossier, Nicolas Véziris, (unknown), (unknown), Euloge Ekaza, (unknown), (unknown), (unknown), Vincent Jarlier	0
12	A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis 2008 ·American Journal of Respiratory and Critical Care Medicine ·Nicolas Véziris, (unknown), Nacer Lounis, Aurélie Chauffour, C. Truffot-Pernot, Koen Andries, Vincent Jarlier	51
13	Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide 2008 ·Clinical Microbiology and Infection ·Laurence Drieux, Florence Brossier, Wladimir Sougakoff, Vincent Jarlier	359
14	A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis breakdown → 2004 ·Science ·Koen Andries, Peter Verhasselt, Jérôme Guillemont, Hinrich W. H. Göhlmann, Jean‐Marc Neefs, Hans Christian Winkler, Jef Van Gestel, Philip Timmerman, Min Zhu, (unknown), Peter Williams, (unknown), Emma Huitric, Sven Hoffner, Emmanuelle Cambau, C. Truffot-Pernot, Nacer Lounis, Vincent Jarlier	1632
15	Quels sont les nouveaux outils diagnostiques de la tuberculose ? Quel est leur intérêt pour la prise en charge du malade et quelles sont leurs indications ? Les tests d'amplification génique 2004 ·Revue des Maladies Respiratoires ·Vincent Jarlier, Emmanuelle Cambau, Wladimir Sougakoff	2
16	La résistance bactérienne aux antibiotiques en France : une priorité en santé publique 2000 ·Eurosurveillance ·(unknown), Jean Carlet, Patrice Courvalin, J C Desenclos, J Drucker, Didier Guillemot, Vincent Jarlier, B. Régnier, Benoı̂t Schlemmer	2
17	Outcome of Multi-drug-resistant Tuberculosis in France: A Nationwide Case-Control Study 1999 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), J. Robert, Vincent Jarlier, J Grosset	75
18	Purification, Crystallization, and Preliminary X-Ray Diffraction Analysis of the Carbapenem-Hydrolyzing Class A β-Lactamase Sme-1 fromSerratia marcescens 1996 ·Journal of Structural Biology ·Wladimir Sougakoff, Vincent Jarlier, J. Delettré, N. Colloc’h, Guillaume L’Hermite, Patrice Nordmann, Thierry Naas	5
19	Amplification and nucleotide sequence of the quinolone resistance-determining region in thegyrAgene of mycobacteria 1994 ·FEMS Microbiology Letters ·Emmanuelle Cambau, Wladimir Sougakoff, Vincent Jarlier	31
20	[Evolution of the resistance of Streptococcus pneumoniae to erythromycin at the Pitié-Salpêtrière Hospital (1980-1984)]. 1986 ·PubMed ·Jacqueline Nguyen, Vincent Jarlier, Bertrand Dautzenberg, (unknown), Olof Axler, A. Moreau, M.‐H. Fievet	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact